Patents by Inventor Shangjun Teng

Shangjun Teng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for preparing alkynyl-containing compound and intermediate thereof
    Patent number: 12152025
    Abstract: Disclosed herein are a process for preparing alkynyl-containing compound and intermediate thereof.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: November 26, 2024
    Assignees: Ascentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Goup Corp Limited, GUANGZHOU HEALTHQUEST PHARMA CO., LTD.
    Inventors: Ming Guo, Jianfeng Wen, Shangjun Teng, Tianzhu Wu, Jianpeng Feng
  • A PROCESS FOR PREPARING ALKYNYL-CONTAINING COMPOUND AND INTERMEDIATE THEREOF
    Publication number: 20220112186
    Abstract: Disclosed herein are a process for preparing alkynyl-containing compound and intermediate thereof.
    Type: Application
    Filed: February 26, 2020
    Publication date: April 14, 2022
    Inventors: Ming Guo, Jianfeng Wen, Shangjun Teng, Tianzhu Wu, Jianpeng Feng
  • Chemical process for preparing spiroindolones and intermediates thereof
    Patent number: 9598712
    Abstract: The present invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds such as (1?R,3?S)-5,7?-dichloro-6?-fluoro-3?-methyl-2?,3?,4?,9?-tetrahydrospiro[indoline-3,1?-pyrido[3,4-b]indol]-2-one and salts and hydrates and solvates thereof.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: March 21, 2017
    Assignee: Novartis AG
    Inventors: Michael Crowe, Michael Foulkes, Giancarlo Francese, Dominique Grimler, Ernst Kuesters, Kurt Laumen, Yunzhong Li, Changxue Lin, Jovana Nazor, Thomas Ruch, Derek Smith, Shiwei Song, Shangjun Teng
  • Chemical Process for Preparing Spiroindolones and Intermediates Thereof
    Publication number: 20150045562
    Abstract: The present invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds such as (1?R,3?S)-5,7?-dichloro-6?-fluoro-3?-methyl-2?,3?,4?,9?-tetrahydrospiro[indoline-3,1?-pyrido[3,4-b]indol]-2-one and salts and hydrates and solvates thereof.
    Type: Application
    Filed: March 22, 2013
    Publication date: February 12, 2015
    Applicant: Novartis AG
    Inventors: Michael Crowe, Michael Foulkes, Giancarlo Francese, Dominique Grimler, Ernst Kuesters, Kurt Laumen, Yunzhong Li, Changxue Lin, Jovana Nazor, Thomas Ruch, Derek Smith, Shiwei Song, Shangjun Teng